Chemical and Pharmaceutical Bulletin · 2006 · 238 citations · 21 references
PharmacyMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryOral Cancer BiologyMetabolite IdentificationNatural Product Drug DiscoveryAnticancer ActivityAnticancer Natural ProductsFruit Bioactive CompoundsFruit FlavonoidsFruit PhytochemicalsFruit Secondary MetabolitesMaturity Stage EffectsStructural Elucidation From Spectra
Three new prenylated xanthones, mangostenones C (1), D (2), and E (3), together with 16 known xanthones 4-19, were isolated from the young fruit (7-week maturity stage) of Garcinia mangostana. The structural elucidation of the new compounds was mainly established on the basis of 1D and 2D NMR and HR-MS spectroscopic analysis. Compound 1 showed cytotoxic properties against three human cancer cell lines, epidermoid carcinoma of the mouth (KB), breast cancer (BC-1), and small cell lung cancer (NCI-H187), with IC50 values of 2.8, 3.53, and 3.72 microg/ml, respectively. Among the isolates, alpha-mangostin (12), the major metabolite, exhibited the most potent effects against the BC-1 cells with an IC50 value of 0.92 microg/ml, an activity greater than that of the standard drug ellipticine (IC50 = 1.46 microg/ml). Compound 12 also showed the highest activity against KB cells, while gartanin (10) displayed the strongest activity against the NCI-H187 cells at the respective IC50 values of 2.08 microg/ml and 1.08 microg/ml.
21
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations
Medicine, Oncology, Pharmacology +10
Induction of Apoptosis by Xanthones from Mangosteen in Human Leukemia Cell Lines
Kenji Matsumoto, Yukihiro Akao, Emi Kobayashi et al. · Journal of Natural Products · 2003 · 207 citations
Medicine, Oncology, Pharmacology +16
Dry Column Vacuum Chromatography
Daniel Sejer Pedersen, Christoph Rosenbohm · Synthesis · 2002 · 197 citations